Looker Benjamin
Chief Legal Officer
Looker Benjamin has filed 8 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jul 13, 2026.
On the most recent filing, Looker Benjamin is listed as Chief Legal Officer at Esperion Therapeutics, Inc. Inside the rolling window, Looker Benjamin reported no open-market purchases and 4 open-market sales totaling $81K in ESPR. The largest disclosed transaction in the window is a sale of 11,824 ESPR shares on Jun 17, 2026, worth $37K.
Companies traded
Other insiders at ESPR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$81K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Looker Benjamin made?
Looker Benjamin has filed 8 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does Looker Benjamin trade?
Looker Benjamin has filed SEC Form 4 disclosures for 1 company, including ESPR.
When was Looker Benjamin's most recent SEC Form 4 filing?
Looker Benjamin's most recent SEC Form 4 filing on Tracefour is dated Jul 13, 2026.
What is Looker Benjamin's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Looker Benjamin is listed as Chief Legal Officer.
What is Looker Benjamin's total buy and sell value in the current window?
Inside the rolling retention window, Looker Benjamin bought $0 and sold $81K based on SEC Form 4 filings.
What was Looker Benjamin's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,824 ESPR shares on 2026-06-17, worth $37K, per SEC Form 4 filings.